Adverse Reactions to Tremelimumab, Durvalumab in Liver Cancer
In recent years, the advent of immune checkpoint inhibitors has revolutionized the therapeutic landscape of hepatocellular carcinoma (HCC), a primary ...
Tag: immune checkpoint inhibitors in liver cancer
Predicting Liver Injury from Immunotherapy in Liver Cancer
In a groundbreaking study published in BMC Cancer, researchers have made strides in understanding and predicting liver injury induced by ...
Study Explores Immune-Related Side Effects of Liver Cancer Treatment in Latin American Patients
A groundbreaking multinational study has shed new light on immune-mediated adverse events (irAEs) associated with the combination therapy of atezolizumab ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!